Tandem Diabetes Care, a company known for its touchscreen insulin pumps, faced financial difficulties in 2017. Despite these challenges, the company showcased several updates at the American Diabetes Association's Scientific Sessions in June 2017. They emphasized their commitment to innovation and patient care. Key updates included the integration of their pumps with the Dexcom G5 continuous glucose monitor, allowing users to access glucose data directly on their devices. They also announced a mobile app to be released in 2018, which would offer features like alerts, reminders, and data sharing with healthcare providers. Additionally, Tandem introduced a new larger insulin pump, the t:flex X2, and new durable pump cases. They also discussed future technologies like Predictive Low Glucose Suspend (PLGS) and a smaller, more discreet pump called the t:sport. Tandem's efforts to improve their products and services aimed to reassure patients and investors about their future.